drugset / Trial / NCT01228084
Sulforaphane in Treating Patients With Recurrent Prostate Cancer
Phase 2
Completed
20 enrolled
OHSU Knight Cancer Institute
The Wayne D. Kuni and Joan E. Kuni Foundation · collab
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial studies how well sulforaphane works in treating patients with recurrent prostate cancer. Sulforaphane may prevent or slow the growth of certain cancers.
Timeline
- Start
- 2010-11
- Primary completion
- 2012-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sulforaphane | Small molecule | 0.2 mmol | Oral |